Cerise Pharmaceuticals Private Limited
About Cerise Pharmaceuticals Private Limited
Data last updated:
Cerise Pharmaceuticals Private Limited is a private limited company based in Palgarh, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 29 December 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24132MH2014PTC260450. Its GSTIN is 09AAXCS0280J1ZQ (Uttar Pradesh).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It was formerly known as Berry Pharmaceuticals Private Limited and Sunshine Pharmaceuticals Private Limited. It is led by directors Shailesh Kumar Pandey and Satya Prakash Pandey.
Its last annual general meeting (AGM) was held on 30 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office is at Shop No.1 Chaubey Compound Sitaram Nagar Santosh Bhavan Nallasopara (E.), Palgarh, Maharashtra, India – 401209.
As per the financials filed for FY 2018, the company reported a revenue of ₹2.62 Lakh. For the same year it recorded a net profit of ₹18,958 (net margin 7.2%) and EBITDA of ₹30,002 (EBITDA margin 11.4%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Name history
Cerise Pharmaceuticals has undergone 3 name changes throughout its history. The company was previously known as Berry Pharmaceuticals Private Limited, Sunshine Pharmaceuticals Private Limited, and Cirese Pharmaceuticals Private Limited. The current legal name is Cerise Pharmaceuticals Private Limited.
| Company Name | Status |
|---|---|
| Cerise Pharmaceuticals Private Limited | Current |
| Berry Pharmaceuticals Private Limited | Previous |
| Sunshine Pharmaceuticals Private Limited | Previous |
| Cirese Pharmaceuticals Private Limited | Previous |
Contact details
Cerise Pharmaceuticals Private Limited's registered office is in Palgarh, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No.1 Chaubey Compound Sitaram Nagar Santosh Bhavan Nallasopara (E.), Palgarh, Maharashtra, India – 401209
- IndustryChemicals, Manufacturing, Basic Chemical, Phenolic-Resins & Polyurethanes, Amino-Resins
To see the full contact details of Cerise Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cerise Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Cerise Pharmaceuticals Private Limited, buy the company report.
Financials of Cerise Pharmaceuticals Private Limited
FY 2018 filings availableCerise Pharmaceuticals Private Limited reported revenue of ₹2.62 Lakh for FY 2018.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹30,002 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹18,958 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 11.4% | |||
| Net Profit Margin | 7.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Cerise Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cerise Pharmaceuticals Private Limited
Cerise Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shailesh Kumar Pandey | Director | 29 Dec 2014 | 11 Years 10 Months | Current |
| Satya Prakash Pandey | Director | 29 Dec 2014 | 11 Years 10 Months | Current |
Peer comparison
Cerise Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Reverie Pharmaceuticals Private Limited | ₹2.7 Lakh (FY 2025) | -33.0% | Ahmedabad, Gujarat, India | |||
| Exlr Pharmaceuticals Private Limited | ₹2.68 Lakh (FY 2024) | 84.0% | Hyderabad, Telangana, India | |||
| Griffix Pharmaceuticals Private Limited | ₹2.63 Lakh (FY 2023) | -47.0% | New Delhi, Delhi, India | |||
| Cerise Pharmaceuticals Private Limitedthis company | ₹2.62 Lakh (FY 2018) | ₹18,958 | 7.2% | Palgarh, Maharashtra, India | ||
| Chembiorix Pharmaceuticals Private Limited | ₹2.62 Lakh (FY 2024) | Aligarh, Uttar Pradesh, India | ||||
| Diarhytham Pharmaceuticals Private Limited | ₹2.6 Lakh (FY 2025) | -37.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Cerise Pharmaceuticals Private Limited, buy the company report.
Auditor
Cerise Pharmaceuticals Private Limited is audited by AKS AKS & Associates for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AKS AKS & Associates | FY 2017 | 014389C |
Shareholding
The shareholding of Cerise Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Cerise Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cerise Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cerise Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cerise Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAXCS0280J1ZQ | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Cerise Pharmaceuticals Private Limited, buy the company report.
Recent activity
Cerise Pharmaceuticals Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Satya Prakash Pandey was appointed as Director on 29 Dec 2014.
Frequently asked questions
Cerise Pharmaceuticals is an active private limited company based in Palgarh, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 29 December 2014 (12+ years old) and is registered under CIN U24132MH2014PTC260450.
Cerise Pharmaceuticals has 2 current directors:
- Shailesh Kumar Pandey - Director
- Satya Prakash Pandey - Director
The latest financial statements of Cerise Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 30 September 2018. Year-wise statements from 2015 are in the company report.
The GSTIN of Cerise Pharmaceuticals is 09AAXCS0280J1ZQ, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Cerise Pharmaceuticals is U24132MH2014PTC260450. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cerise Pharmaceuticals was incorporated on 29 December 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Cerise Pharmaceuticals by revenue are Reverie Pharmaceuticals Private Limited, Exlr Pharmaceuticals Private Limited, Griffix Pharmaceuticals Private Limited, Chembiorix Pharmaceuticals Private Limited, Diarhytham Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Satya Prakash Pandey was appointed as Director on 29 Dec 2014. Shailesh Kumar Pandey was appointed as Director on 29 Dec 2014.
The registered office of Cerise Pharmaceuticals is at Shop No.1 Chaubey Compound Sitaram Nagar Santosh Bhavan Nallasopara E., Palgarh, Maharashtra, India – 401209.
Cerise Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
The compliance status of Cerise Pharmaceuticals is compliant as of 24 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
